Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93
description
Transcript of Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93
![Page 1: Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93](https://reader035.fdocuments.in/reader035/viewer/2022062500/5681598d550346895dc6d742/html5/thumbnails/1.jpg)
Effect of a 6-day icv ghrelin infusion (2.5 nmol/d) on cumulative food intake (A), body weight gain
(B), food efficiency (C), and fat mass gain (D)
Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93
Values are mean ± SEM of 6–7 animals per group*P < 0.05 versus control; #P < 0.05 versus ghrelin-pf
![Page 2: Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93](https://reader035.fdocuments.in/reader035/viewer/2022062500/5681598d550346895dc6d742/html5/thumbnails/2.jpg)
Effects of icv ghrelin infusion on total energy expenditure and RQ
Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93
![Page 3: Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93](https://reader035.fdocuments.in/reader035/viewer/2022062500/5681598d550346895dc6d742/html5/thumbnails/3.jpg)
Effects of icv ghrelin infusion on plasma bioactive ghrelin, glucose, insulin, corticosterone, leptin,
FFA, and TG levels
Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93
![Page 4: Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93](https://reader035.fdocuments.in/reader035/viewer/2022062500/5681598d550346895dc6d742/html5/thumbnails/4.jpg)
Effect of a 6-day icv ghrelin infusion (2.5 nmol/day) on insulin-stimulated glucose utilization indices measured during euglycemic-hyperinsulinemic
clamps in epididymal WAT (A), inguinal WAT (B), BAT (C), and soleus muscle (D)
Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93
Values are mean ± SEM of 6–7 animals per group *P < 0.05 versus control; #P < 0.05 versus ghrelin-pf
![Page 5: Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93](https://reader035.fdocuments.in/reader035/viewer/2022062500/5681598d550346895dc6d742/html5/thumbnails/5.jpg)
Effect of a 6-day icv ghrelin infusion (2.5 nmol/d) on epididymal WAT mRNA expression
of LPL (A), ACC (B), and CPT-1α (C)
Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93
Values are mean ± SEM of 6–7 animals per group *P < 0.05 versus control; #P < 0.05 versus ghrelin-pf
![Page 6: Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93](https://reader035.fdocuments.in/reader035/viewer/2022062500/5681598d550346895dc6d742/html5/thumbnails/6.jpg)
Effect of a 6-day icv ghrelin infusion (2.5 nmol/d) on epididymal WAT mRNA expression of FAS (A) and SCD1 (B), and on epididymal protein expression of WAT FAS
(C) and SCD1 (D), with one representative Western blot (of the 2 performed)
Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93
Values are mean ± SEM of 6–7 animals per group *P < 0.05 versus control; #P < 0.05 versus ghrelin-pf
![Page 7: Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93](https://reader035.fdocuments.in/reader035/viewer/2022062500/5681598d550346895dc6d742/html5/thumbnails/7.jpg)
Effect of a 6-day icv ghrelin infusion (2.5 nmol/d) on BAT UCP1 (A) and UCP3 (B)
Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93
Values are mean ± SEM of 6–7 animals per group. *P < 0.05 versus control
![Page 8: Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93](https://reader035.fdocuments.in/reader035/viewer/2022062500/5681598d550346895dc6d742/html5/thumbnails/8.jpg)
Effects of acute and chronic icv ghrelin infusion on mRNA expression of LPL, ACC, FAS, and SCD1 in
epididymal WAT
Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93
![Page 9: Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93](https://reader035.fdocuments.in/reader035/viewer/2022062500/5681598d550346895dc6d742/html5/thumbnails/9.jpg)
Effects of peripheral ghrelin infusion on mRNA expression of ACC, FAS, SCD1, LPL, and CPT-1α in epididymal WAT and UCP1 and UCP3 in BAT
Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93
![Page 10: Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93](https://reader035.fdocuments.in/reader035/viewer/2022062500/5681598d550346895dc6d742/html5/thumbnails/10.jpg)
Effect of a 6-day icv ghrelin infusion (2.5 nmol/d) on hypothalamic NPY mRNA expression
Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93
Values are mean ± SEM of 6–7 animals per group. *P < 0.05 versus control
![Page 11: Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93](https://reader035.fdocuments.in/reader035/viewer/2022062500/5681598d550346895dc6d742/html5/thumbnails/11.jpg)
Effect of a 6-day icv ghrelin infusion (2.5 nmol/day) on cumulative food intake (A and B) and
body weight gain (C and D) in WT and TKO mice
Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93
Values are mean ± SEM of 6–7 animals per group. *P < 0.05 versus control
![Page 12: Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93](https://reader035.fdocuments.in/reader035/viewer/2022062500/5681598d550346895dc6d742/html5/thumbnails/12.jpg)
Epididymal WAT mRNA expression of LPL (A) and SCD1 (B) in WT and ghrelin KO mice
Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93
Values are mean ± SEM of 5 animals per group. *P < 0.05 versus WT
![Page 13: Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93](https://reader035.fdocuments.in/reader035/viewer/2022062500/5681598d550346895dc6d742/html5/thumbnails/13.jpg)
Primer sequences used for real-time RT-PCR
Claudia Theander-Carrillo, et al. J. Clin. Invest. 2006 116:1983-93